Overview
This randomized, double-blind, placebo-controlled, and parallel clinical study aims to investigate the effectivness of a pumpkin seed extract on blood sugar management in subhealth people.
Eligibility
Inclusion Criteria:
- Fasting blood sugar levels from 100 to 125 mg/dL
- Glycated hemoglobin levels from 5.7 to 6.4%
- 2-hour OGTT levels from 140 to 199 mg/dL
Exclusion Criteria:
- Pregnant women or preparing for pregnancy.
- Lactating women.
- Women gave birth 6 months before the study.
- Poor kindy funciton
- Severe cardiovascular or other chronic diseases
- Patients with type I or II diabetes
- Poor compliance
- Alcohol abuser
- Using anti-diabetic or weight managent supplements
- Blood transfusion three months before the study
- Pumpkin seed allergy